Circ Cardiovasc Interv

Slides:

Advertisements

Similar presentations

Marshall E. Benjamin, MD, E. Jerry Cohn, MD, William A

Advertisements

Medstar Washington Hospital Center, Washington DC

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

A novel interventional method for treating femoral pseudoaneurysms

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting.

Circ Cardiovasc Qual Outcomes

by Adam J. Singer, Robert H

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Circ Cardiovasc Interv

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Circ Cardiovasc Imaging

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.

Circ Cardiovasc Imaging

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Circ Cardiovasc Imaging

Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease by Ryuichi Morishita, Motokuni Aoki, Naotaka.

Value-Based Hypothesis Testing for Cardiac Device Clinical Trials

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Percutaneous Circulatory Support for Biventricular Failure

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Behavior and Biology: The Basic Sciences for AHA Action

Physician and Patient Influences on Provider Performance

Circ Cardiovasc Interv

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Circ Cardiovasc Interv

Relative Distributions

Left Ventricular Assist Device Outflow Cannula Obstruction Treated With Percutaneous Endovascular Stenting by Jacob Abraham, Joshua D. Remick, Todd Caulfield,

Multimodality Imaging of Lower Extremity Peripheral Arterial Disease

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Effect of Provider Volume on the Accuracy of Hospital Report Cards

Iatrogenic Adverse Events in the Coronary Care Unit

Virtual Reality in Stroke Rehabilitation

Box plot showing percentage change in early diastolic pulsed-Doppler mitral inflow (E)/early diastolic tissue Doppler velocity (E´) from pre– to post–balloon.

Recovery of hypoplastic left heart syndrome (HLHS) mutant by ultrasound phenotyping. Recovery of hypoplastic left heart syndrome (HLHS) mutant by ultrasound.

Supravalvular Aortic Stenosis

Circ Cardiovasc Qual Outcomes

Mathematical representation of Bayes theorem.

Circ Cardiovasc Qual Outcomes

Pulse Pressure and Resistance Artery Structure in the Elderly

Using the Coronary Artery Calcium Score to Guide Statin Therapy

Circ Cardiovasc Interv

Amanda D. Ingram, MD, Mary C. Mahoney, MD

Marshall E. Benjamin, MD, E. Jerry Cohn, MD, William A

H.V. Polavarapu, J.M. Reyes, E.J. Anoia, R.A. Jubelirer EJVES Extra

Successful treatment of an iatrogenic right hepatic artery pseudoaneurysm and stenosis with a stent graft Jared R. Hylton, MS, William C. Pevec, MD

Rick Feld, MD, Gerald M. Patton, MD, R

Treatment of iatrogenic femoral artery pseudoaneurysm with percutaneous thrombin injection Chiau-Suong Liau, MD, Feng-Ming Ho, MD, Ming-Fong Chen, MD,

Robert P. Garvin, MD, Evan J. Ryer, MD, H. Richard Yoon, MD, J

Vascular complications of cardiac catheterization

Surgical versus endovascular treatment of traumatic thoracic aortic rupture Philippe Amabile, MD, Frédéric Collart, MD, Vlad Gariboldi, MD, Gilles Rollet,

Femoral pseudoaneurysms after percutaneous access

Ipsilateral femoral vein compression: A contraindication to thrombin injection of femoral pseudoaneurysms Benjamin Hung, MD, a, Bertrand Gallet, MD,

Walter Pipkin, MD, Colleen Brophy, MD, Robert Nesbit, MD, J

Successful management of traumatic false aneurysm of the extracranial vertebral artery by duplex-directed manual occlusion: A case report Richard L.

Endovascular treatment was performed approximately 8 months after the patient’s initial diagnosis. Endovascular treatment was performed approximately 8.

Ultrasound-guided percutaneous thrombin for the management of superior mesenteric artery pseudoaneurysm Patrick Casey, MBChB, Ambareen Kausar, FRCS,

Spontaneous thrombosis of iatrogenic femoral artery pseudoaneurysms: Documentation with color Doppler and two-dimensional ultrasonography Joseph P. Johns,

A 29-year-old man with sudden neck pain followed by right-sided muscle weakness and difficulty in swallowing. A 29-year-old man with sudden neck pain followed.

Iatrogenic subclavian artery pseudoaneurysm causing airway compromise: treatment with percutaneous thrombin injection Rakesh Jeganathan, MB, BCh, BAO,

Steven S. Kang, MD, Nicos Labropoulos, PhD, M

Giant cavernous carotid aneurysm, with the patient presenting with third and sixth nerve palsy due to mass effect (patient 16, On-line Table and Tables.

Patrick A. Stone, MD, Ali F. AbuRahma, MD, Sarah K. Flaherty, BS

Presentation transcript:

Circ Cardiovasc Interv Safety and Efficacy of a Potential Treatment Algorithm by Using Manual Compression Repair and Ultrasound-Guided Thrombin Injection for the Management of Iatrogenic Femoral Artery Pseudoaneurysm in a Large Patient Cohort by Marijana Dzijan-Horn, Nicolas Langwieser, Philipp Groha, Christian Bradaric, Maryam Linhardt, Corinna Böttiger, Robert A. Byrne, Birgit Steppich, Tobias Koppara, Julia Gödel, Martin Hadamitzky, Ilka Ott, Nicolas von Beckerath, Adnan Kastrati, Karl-Ludwig Laugwitz, and Tareq Ibrahim Circ Cardiovasc Interv Volume 7(2):207-215 April 15, 2014 Copyright © American Heart Association, Inc. All rights reserved.

Flow chart of management of iatrogenic femoral artery pseudoaneurysm (PSA) according to a treatment algorithm based on morphological features of the aneurysm. Flow chart of management of iatrogenic femoral artery pseudoaneurysm (PSA) according to a treatment algorithm based on morphological features of the aneurysm. Marijana Dzijan-Horn et al. Circ Cardiovasc Interv. 2014;7:207-215 Copyright © American Heart Association, Inc. All rights reserved.

Duplex findings of a pseudoaneurysm (PSA) treated with manual compression (MC). Duplex findings of a pseudoaneurysm (PSA) treated with manual compression (MC). A, Ultrasound image of a small PSA directly adjacent to the common femoral artery via an indefinable neck. Duplex scan demonstrates flow within the PSA and the femoral artery. B, After MC, the PSA cavity is thrombosed and echogenic. Duplex scan only shows flow within the femoral artery. FA indicates femoral artery; N, PSA neck; and P, PSA. Marijana Dzijan-Horn et al. Circ Cardiovasc Interv. 2014;7:207-215 Copyright © American Heart Association, Inc. All rights reserved.

Duplex findings of a pseudoaneurysm (PSA) treated with ultrasound-guided thrombin injection (UGTI). Duplex findings of a pseudoaneurysm (PSA) treated with ultrasound-guided thrombin injection (UGTI). A, Image of a dual-chamber PSA with a definable neck before thrombin injection. Duplex scan demonstrates flow within the PSA, the PSA neck, and the femoral artery. B, Duplex scan of the PSA cavity showing partial PSA obliteration during thrombin injection in the lobe not closest to the artery. C, After UGTI, the PSA is completely thrombosed and echogenic. Duplex scan only show flow within the femoral artery. FA indicates femoral artery; N, PSA neck; and P, PSA. Marijana Dzijan-Horn et al. Circ Cardiovasc Interv. 2014;7:207-215 Copyright © American Heart Association, Inc. All rights reserved.

Overview of application and success of the institutional treatment algorithm including crossover treatment and alternative therapy. Overview of application and success of the institutional treatment algorithm including crossover treatment and alternative therapy. Marijana Dzijan-Horn et al. Circ Cardiovasc Interv. 2014;7:207-215 Copyright © American Heart Association, Inc. All rights reserved.